NCT05653960View on ClinicalTrials.gov

Clinical Outcomes After EMR or ESD of Colorectal Neoplasms - A Multicenter Registry

Not yet recruitingOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 31, 2033

Study Completion Date

December 31, 2033

Conditions
Colorectal CancerColorectal NeoplasmsColorectal Adenoma
Interventions
OTHER

EMR or ESD

Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are two main endoscopic treatment options for colorectal neoplasms

Trial Locations (1)

Unknown

Prince of Wales Hospital, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT05653960 - Clinical Outcomes After EMR or ESD of Colorectal Neoplasms - A Multicenter Registry | Biotech Hunter | Biotech Hunter